HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

First neuropathological description of a patient with Parkinson's disease and LRRK2 p.N1437H mutation.

Abstract
The c.4309A>C mutation in the LRRK2 gene (LRRK2 p.N1437H) has recently been reported as the seventh pathogenic LRRK2 mutation causing monogenic Parkinson's disease (PD). So far, only two families worldwide have been identified with this mutation. By screening DNA from seven brains of PD patients, we found one individual with seemingly sporadic PD and LRRK2 p.N1437H mutation. Clinically, the patient had levodopa-responsive PD with tremor, and developed severe motor fluctuations during a disease duration of 19 years. There was severe and painful ON-dystonia, and severe depression with suicidal thoughts during OFF. In the advanced stage, cognition was slow during motor OFF, but there was no noticeable cognitive decline. There were no signs of autonomic nervous system dysfunction. Bilateral deep brain stimulation of the subthalamic nucleus had unsatisfactory results on motor symptoms. The patient committed suicide. Neuropathological examination revealed marked cell loss and moderate alpha-synuclein positive Lewy body pathology in the brainstem. There was sparse Lewy pathology in the cortex. A striking finding was very pronounced ubiquitin-positive pathology in the brainstem, temporolimbic regions and neocortex. Ubiquitin positivity was most pronounced in the white matter, and was out of proportion to the comparatively weaker alpha-synuclein immunoreactivity. Immunostaining for tau was mildly positive, revealing non-specific changes, but staining for TDP-43 and FUS was entirely negative. The distribution and shape of ubiquitin-positive lesions in this patient differed from the few previously described patients with LRRK2 mutations and ubiquitin pathology, and the ubiquitinated protein substrate remains undefined.
AuthorsAndreas Puschmann, Elisabet Englund, Owen A Ross, Carles Vilariño-Güell, Sarah J Lincoln, Jennifer M Kachergus, Stephanie A Cobb, Anna-Lena Törnqvist, Stig Rehncrona, Håkan Widner, Zbigniew K Wszolek, Matthew J Farrer, Christer Nilsson
JournalParkinsonism & related disorders (Parkinsonism Relat Disord) Vol. 18 Issue 4 Pg. 332-8 (May 2012) ISSN: 1873-5126 [Electronic] England
PMID22154298 (Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Video-Audio Media)
CopyrightCopyright © 2011 Elsevier Ltd. All rights reserved.
Chemical References
  • DNA-Binding Proteins
  • RNA-Binding Protein FUS
  • Ubiquitin
  • alpha-Synuclein
  • Histidine
  • Asparagine
  • LRRK2 protein, human
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Protein Serine-Threonine Kinases
Topics
  • Aged
  • Asparagine (genetics)
  • Brain (metabolism, pathology)
  • DNA Mutational Analysis
  • DNA-Binding Proteins (metabolism)
  • Family Health
  • Female
  • Histidine (genetics)
  • Humans
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Magnetic Resonance Imaging
  • Male
  • Parkinson Disease (genetics, pathology)
  • Protein Serine-Threonine Kinases (genetics)
  • RNA-Binding Protein FUS (metabolism)
  • Ubiquitin (metabolism)
  • alpha-Synuclein (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: